Search filters

List of works by Shirley D'Sa

A RANDOMIZED PHASE 3 TRIAL OF ZANUBRUTINIB VERSUS IBRUTINIB IN SYMPTOMATIC WALDENSTRÖM MACROGLOBULINEMIA:THE ASPEN STUDY

scientific article published on 30 July 2020

A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1

scientific article published on 09 July 2018

A prognostic index predicting survival in transformed Waldenström macroglobulinemia

scientific article published on 12 November 2020

Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study

scientific article published on 19 December 2019

Advances in POEMS treatment and the need to define standardised outcome measures

scientific article published on 29 October 2018

An alternative dosing strategy of lenalidomide for patients with relapsed multiple myeloma

scientific article published on 8 August 2014

Assessing diversity: immune reconstitution and T-cell receptor BV spectratype analysis following stem cell transplantation

scientific article published on 01 January 2003

Assessing the Relation Between Bone Marrow Signal Intensity and Apparent Diffusion Coefficient in Diffusion-Weighted MRI

scientific article published on January 1, 2013

Bone marrow assessment in asymptomatic IgM monoclonal gammopathies - reply to Varettoni et al.

scientific article published on 27 August 2014

Bortezomib-induced inflammatory neuropathy.

scientific article published on December 2010

Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.

scientific article

Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort study

scientific article published on 30 June 2020

Cold agglutinin disease revisited: A multinational, observational study of 232 patients

scientific article published on 06 May 2020

Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic

scientific article published on 30 July 2020

Consensus treatment recommendations from the tenth International Workshop for Waldenström Macroglobulinaemia

scientific article published on 01 November 2020

Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens

scientific article published on 01 August 2005

Daratumumab for disabling cold agglutinin disease refractory to B-cell directed therapy

scientific article published on 11 July 2020

Diffusion‐weighted MRI compared to FDG PET‐CT in the staging and response assessment of Hodgkin lymphoma ⬇️

scientific article published on December 8, 2011

Early VEGF testing in inflammatory neuropathy avoids POEMS syndrome misdiagnosis and associated costs

scientific article published on 26 October 2020

Elevated lactate dehydrogenase levels detected during routine follow-up do not predict relapse in patients with diffuse large B-cell lymphoma who achieve complete remission after primary treatment with rituximab, cyclophosphamide, doxorubicin, vincr

scientific article published on May 22, 2012

Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects

scientific article

Frequent central nervous system, pachymeningeal and plexus MRI changes in POEMS syndrome

article

Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome

scientific article

Guidelines for supportive care in multiple myeloma 2011.

scientific article published on 22 April 2011

Guidelines for the diagnosis and management of multiple myeloma 2011 ⬇️

scientific article published on May 14, 2011

Guidelines for the use of imaging in the management of myeloma.

scientific article published in April 2007

Guidelines on the diagnosis and management of Waldenström macroglobulinaemia

scientific article published on 15 February 2014

High prevalence of the MYD88 L265P mutation in IgM anti-MAG paraprotein-associated peripheral neuropathy.

scientific article published on 10 October 2017

High rates of venous and arterial thrombotic events in patients with POEMS syndrome: results from the UCLH (UK) POEMS Registry

scientific article published on 01 May 2020

High-dose therapy and autologous transplantation for POEMS Syndrome: effective, but how to optimise?

scientific article published on 18 June 2019

IgM paraprotein-associated peripheral neuropathy: small CD20-positive B-cell clones may predict a monoclonal gammopathy of neurological significance and rituximab responsiveness

scientific article published on 06 October 2019

Improved response with post‐ASCT consolidation by low dose thalidomide, cyclophosphamide and dexamethasone as first line treatment for multiple myeloma ⬇️

scientific article published on June 19, 2012

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial

scientific article published on 17 December 2018

Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program

scientific article published on 01 March 2020

Investigation and management of IgM and Waldenström-associated peripheral neuropathies: recommendations from the IWWM-8 consensus panel

scientific article published on 15 February 2017

Low-dose thalidomide in combination with oral weekly cyclophosphamide and pulsed dexamethasone is a well tolerated and effective regimen in patients with relapsed and refractory multiple myeloma

scientific article published in June 2005

Ofatumumab is a feasible alternative anti-CD20 therapy in patients intolerant of rituximab.

scientific article

POEMS neuropathy: optimising diagnosis and management.

scientific article published on 6 March 2018

Peripheral nerve neurolymphomatosis: clinical features, treatment and outcomes

scientific article published on 12 August 2020

Prevalence and Course of Endocrinopathy in POEMS Syndrome

scientific article published on 01 June 2019

Raised VEGF: High sensitivity and specificity in the diagnosis of POEMS syndrome

article published in 2018

Real world experience of bortezomib re-treatment for patients with multiple myeloma at first relapse

scientific article published on 08 April 2016

Real-world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi-centre UK experience

scientific article

Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: Limited efficacy of graft-versus-tumor activity

scientific article published on 01 April 2003

Rituximab responsive multiple radiculopathies and cranial nerve palsies in association with chronic lymphocytic leukaemia

scientific article published on 02 September 2011

Spinal disease in myeloma: cohort analysis at a specialist spinal surgery centre indicates benefit of early surgical augmentation or bracing

scientific article

T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated don

scientific article published on 01 October 2003

Therapie einer Lymphknotentuberkulose

scientific article published on 01 August 2010

Treatment for lymph node tuberculosis

scientific article published in the British Medical Journal

Treatment of diffuse large B-cell lymphoma with secondary central nervous system involvement: encouraging efficacy using CNS-penetrating R-IDARAM chemotherapy

scientific article published on 18 December 2015

UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS).

scientific article published on 10 August 2009

Untangling a case of painful neuropathy

scientific article published on 04 October 2019

Weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myeloma

scientific article published on 14 March 2013

Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response

scientific article published on 21 October 2016

Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction

scientific article published on 27 June 2017

Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trial

scientific article published on 01 December 2020

[18F]Florbetaben PET-CT confirms AL amyloidosis in a patient with Waldenström's Macroglobulinemia.

scientific article published on 12 April 2018

Paulina is supported by:

About Paulina

Help